Article Details
Retrieved on: 2022-06-20 13:06:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Valneva will use the proceeds from Pfizer's equity investment to support its Phase III development contribution to the Lyme disease program. A person ...
Article found on: www.pharmalive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here